View Older Stories

Jan 21, 2026 04:14PM BridgeBio issues $632.5 million convertible notes due 2033

Jan 12, 2026 01:42PM TD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Jan 12, 2026 10:31AM BridgeBio reports $362.4 million in Attruby revenue for 2025

Jan 6, 2026 02:11AM Morgan Stanley Starts BridgeBio Pharma (BBIO) at Overweight

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 21, 2025 08:00PM Here's the list of top biotech stocks to own for 2026

Dec 11, 2025 12:58AM Bernstein SocGen Group Starts BridgeBio Pharma (BBIO) at Outperform

Nov 10, 2025 02:33AM BridgeBio's acoramidis shows mortality benefit in ATTR-CM variant patients

Oct 30, 2025 09:39AM BridgeBio Pharma (BBIO) PT Raised to at TD Cowen as 'Attruby Beats Expectations Again'

Oct 30, 2025 06:20AM BridgeBio Pharma (BBIO) PT Raised to $100 at Goldman Sachs

Oct 30, 2025 05:37AM BridgeBio Pharma (BBIO) PT Raised to $75 at Leerink Partners

Oct 29, 2025 04:13PM BridgeBio Pharma Inc. (BBIO) Misses Q3 EPS by 7c

Oct 28, 2025 06:41AM BridgeBio Pharma (BBIO) PT Raised to $80 at H.C. Wainwright

Oct 27, 2025 01:30PM BridgeBio Pharma (BBIO) PT Raised to $69 at Raymond James

Oct 27, 2025 10:22AM BridgeBio Pharma (BBIO) PT Raised to $68 at Leerink Partners

Oct 27, 2025 09:20AM BridgeBio Pharma (BBIO) PT Raised to $90 at Evercore ISI

Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'

Oct 17, 2025 08:32AM Truist Securities: 'Is Biotech Back?!'

Sep 30, 2025 08:01AM Piper Sandler Sees 'A Good Setup for BridgeBio Pharma (BBIO) Shares to Outperform'

Sep 23, 2025 08:48AM UBS Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Sep 22, 2025 09:09AM UBS Reiterates Buy Rating on BridgeBio Pharma (BBIO), Cites Confidence in Attruby

Sep 15, 2025 07:32AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Sep 12, 2025 09:01AM BridgeBio Pharma (BBIO) PT Raised to $82 at UBS on ADH1 Optimism

Sep 11, 2025 08:55AM UBS Reiterates Buy Rating on BridgeBio Pharma (BBIO), Optimistic on Encaleret

Sep 10, 2025 02:38PM TD Cowen on BridgeBio Pharma (BBIO): 'We anticipate an approval in 2026 with peak sales approaching $1B'

Sep 10, 2025 10:26AM Truist Securities Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Sep 10, 2025 10:00AM Jefferies Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Sep 8, 2025 07:12AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Sep 3, 2025 06:59AM BridgeBio Pharma (BBIO) Added to JPMorgan Positive Catalyst Watch List

Sep 3, 2025 06:59AM BridgeBio Pharma (BBIO) PT Raised to $70 at JPMorgan

Sep 2, 2025 06:56AM BridgeBio Pharma (BBIO) PT Raised to $70 at H.C. Wainwright

Aug 6, 2025 01:51PM TD Cowen on BridgeBio Pharma (BBIO): 'Attruby Is a Winner'

Aug 6, 2025 06:07AM BridgeBio Pharma (BBIO) PT Raised to $61 at Oppenheimer

Aug 5, 2025 05:47PM BridgeBio Pharma Inc. (BBIO) Misses Q2 EPS by 20c

Jul 29, 2025 04:24PM Raymond James Assumes BridgeBio Pharma (BBIO) at Outperform

Jul 29, 2025 08:25AM Cantor Fitzgerald Reiterates Overweight Rating on BridgeBio Pharma (BBIO)

Jul 23, 2025 07:31AM BridgeBio study finds ADH1 genetic condition underdiagnosed by 80%

Jul 21, 2025 07:29AM Truist Securities Starts BridgeBio Pharma (BBIO) at Buy

Jul 18, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Jul 14, 2025 05:46AM Citi Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Jul 14, 2025 12:54AM Jefferies Starts BridgeBio Pharma (BBIO) at Buy

Jul 11, 2025 07:45AM Helix Acquisition and BridgeBio Oncology receive SEC approval for merger

Jul 9, 2025 06:04AM Oppenheimer Upgrades BridgeBio Pharma (BBIO) to Outperform

Jul 3, 2025 06:43AM Cantor Fitzgerald Reiterates Overweight Rating on BridgeBio Pharma (BBIO)

Jun 30, 2025 02:27PM Raymond James Reiterates Outperform Rating on BridgeBio Pharma (BBIO)

Jun 30, 2025 10:57AM Citi Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Jun 30, 2025 07:30AM BridgeBio Pharma (BBIO) Raises $300 Million Through Partial Capped Monetization of BEYONTTRA European Royalty

Jun 17, 2025 05:53AM Wolfe Research Starts BridgeBio Pharma (BBIO) at Outperform

Jun 9, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Jun 6, 2025 07:27AM Piper Sandler Highlights an 'Under-The-Radar 2H25 Catalyst' at BridgeBio Pharma (BBIO)

View Older Stories